Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Mechanism of action of newly developed vitamin D analogue.

Okamoto S, Ejima E, Kiriyama T, Izumi M, Komori A, Suzuki H, Katsumata T, Nagata A.

Contrib Nephrol. 1991;91:146-8.

PMID:
1666031
2.
3.

Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.

Inaba M, Okuno S, Nishizawa Y, Yukioka K, Otani S, Matsui-Yuasa I, Morisawa S, DeLuca HF, Morii H.

Arch Biochem Biophys. 1987 Nov 1;258(2):421-5.

PMID:
2823715
5.

Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone in the rat.

Ishizuka S, Ishimoto S, Norman AW.

J Steroid Biochem. 1984 Feb;20(2):611-5.

PMID:
6323873
6.

Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.

Norman AW, Okamura WH, Farach-Carson MC, Allewaert K, Branisteanu D, Nemere I, Muralidharan KR, Bouillon R.

J Biol Chem. 1993 Jul 5;268(19):13811-9.

7.

Synthesis and biological activity of (22E,25R)- and (22,25S)-22-dehydro- 1 alpha,25-dihydroxy-26-methylvitamin D3.

Hara N, Eguchi T, Ikekawa N, Ishizuka S, Sato J.

J Steroid Biochem. 1990 May;35(6):655-64.

PMID:
2163469
8.

Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.

Slatopolsky E, Finch J, Ritter C, Takahashi F.

Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S40-7.

PMID:
9808142
9.
10.

Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.

Mehta RG, Moriarty RM, Mehta RR, Penmasta R, Lazzaro G, Constantinou A, Guo L.

J Natl Cancer Inst. 1997 Feb 5;89(3):212-8.

PMID:
9017001
11.

Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.

Miyahara T, Harada M, Kozakai A, Matsumoto M, Hashimoto K, Inoue H, Yoda K, Nakatsu T, Kajita S, Yamazaki R, Higuchi S, Kozuka H, Nemoto N.

J Nutr Sci Vitaminol (Tokyo). 1999 Jun;45(3):239-49.

PMID:
10524344
14.

[Regulation of 1,25(OH)2D3 (calcitriol) receptor by vitamin B6].

Sergeev MN, Spirichev VB.

Biokhimiia. 1990 Aug;55(8):1527-31. Russian.

PMID:
1963092
15.

Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.

Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E, Katsumata T, Masuhiro Y, Matsuda K, Ebihara K, et al.

Biochemistry. 1995 Jan 10;34(1):370-7.

PMID:
7819220
16.

Synthesis and biological activity of vitamin D3 analogues.

Ikekawa N.

J Steroid Biochem. 1983 Jul;19(1C):907-11.

PMID:
6310260
17.
18.
19.

Physiological importance of vitamin D metabolism.

Haussler MR, Chandler JS, Pike JW, Brumbaugh PF, Speer DP, Pitt MJ.

Prog Biochem Pharmacol. 1980;17:134-42.

PMID:
6259650
20.

A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.

Greising DM, Schwartz Z, Posner GH, Sylvia VL, Dean DD, Boyan BD.

J Cell Physiol. 1997 Jun;171(3):357-67.

PMID:
9180905

Supplemental Content

Support Center